• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肺动脉高压]

[Pulmonary arterial hypertension].

作者信息

Reichenberger F, Voswinckel R

机构信息

Abteilung Pneumologie, Medizinische Klink II, Universitätsklinikum Gießen Marburg GmbH, Gießen.

出版信息

Internist (Berl). 2011 Apr;52(4):405-14; quiz 415. doi: 10.1007/s00108-011-2810-y.

DOI:10.1007/s00108-011-2810-y
PMID:21331640
Abstract

Pulmonary arterial hypertension is a chronic disorder of the pulmonary circulation characterized by an increased pulmonary artery pressure and an impaired cardiac function. It can present as idiopathic form or associated with several systemic diseases. Typical symptoms include progressive dyspnoea and exercise intolerance. When pulmonary arterial hypertension is suspected, echocardiography is the key investigation for noninvasive assessment of the disease. The diagnosis requires an invasive measurement of pulmonary hemodynamics by right heart catheterization. Treatment is based on general measures and application of pulmonary vasoactive compounds, such as prostanoids, endothelin receptor blockers and phosphodiesterase 5 inhibitors. These treatment options can be combined at progression of the disease. Lung transplantation might be an option in patients refractory to medical therapy.

摘要

肺动脉高压是一种肺循环的慢性疾病,其特征为肺动脉压力升高和心功能受损。它可表现为特发性形式或与多种全身性疾病相关。典型症状包括进行性呼吸困难和运动不耐受。当怀疑有肺动脉高压时,超声心动图是对该疾病进行无创评估的关键检查。诊断需要通过右心导管插入术对肺血流动力学进行有创测量。治疗基于一般措施以及应用肺血管活性化合物,如前列环素、内皮素受体拮抗剂和磷酸二酯酶5抑制剂。在疾病进展时,这些治疗选择可以联合使用。对于药物治疗无效的患者,肺移植可能是一种选择。

相似文献

1
[Pulmonary arterial hypertension].[肺动脉高压]
Internist (Berl). 2011 Apr;52(4):405-14; quiz 415. doi: 10.1007/s00108-011-2810-y.
2
[Pulmonary arterial hypertension].[肺动脉高压]
Medicina (Kaunas). 2007;43(12):978-94.
3
Changes in right ventricular function measured by cardiac magnetic resonance imaging in patients receiving pulmonary arterial hypertension-targeted therapy: the EURO-MR study.肺动脉高压靶向治疗患者右心室功能的心脏磁共振成像测量变化:EURO-MR 研究。
Circ Cardiovasc Imaging. 2014 Jan;7(1):107-14. doi: 10.1161/CIRCIMAGING.113.000629. Epub 2013 Oct 30.
4
Prevalence, Diagnosis, Perioperative Monitoring and Treatment of Right Ventricular Dysfunction and/or Pulmonary Arterial Hypertension in Cardiac Surgical Patients in Germany-A Postal Survey.德国心脏外科手术患者右心室功能障碍和/或肺动脉高压的患病率、诊断、围手术期监测及治疗——一项邮寄调查
Thorac Cardiovasc Surg. 2017 Dec;65(8):593-600. doi: 10.1055/s-0036-1572511. Epub 2016 Feb 24.
5
Pulmonary arterial hypertension: a current review of pharmacological management.肺动脉高压:药物治疗现状综述
Pneumonol Alergol Pol. 2016;84(1):47-61. doi: 10.5603/PiAP.a2015.0084. Epub 2015 Dec 23.
6
Changes in right heart haemodynamics and echocardiographic function in an advanced phenotype of pulmonary hypertension and right heart dysfunction associated with pulmonary fibrosis.肺纤维化相关肺动脉高压及右心功能障碍晚期表型的右心血液动力学和超声心动图功能变化。
Thorax. 2014 Feb;69(2):123-9. doi: 10.1136/thoraxjnl-2013-204150.
7
Pulmonary arterial hypertension: an update on diagnosis and treatment.肺动脉高压:诊断与治疗的最新进展。
Am Fam Physician. 2010 Aug 15;82(4):370-7.
8
Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.先天性体-肺分流及艾森曼格综合征相关肺动脉高压的管理
Drugs. 2008;68(8):1049-66. doi: 10.2165/00003495-200868080-00004.
9
Treatment for pulmonary hypertension including lung transplantation.肺动脉高压的治疗包括肺移植。
Gen Thorac Cardiovasc Surg. 2011 Aug;59(8):538-46. doi: 10.1007/s11748-010-0747-z. Epub 2011 Aug 18.
10
Endothelin receptor antagonists for pulmonary arterial hypertension.用于治疗肺动脉高压的内皮素受体拮抗剂。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD004434. doi: 10.1002/14651858.CD004434.pub3.

本文引用的文献

1
[Treatment of pulmonary arterial hypertension (PAH): recommendations of the Cologne Consensus Conference 2010].[肺动脉高压(PAH)的治疗:2010年科隆共识会议推荐意见]
Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S87-101. doi: 10.1055/s-0030-1263316. Epub 2010 Sep 22.
2
[Pulmonary hypertension: hemodynamic evaluation: hemodynamic evaluation – recommendations of the Cologne Consensus Conference 2010].[肺动脉高压:血流动力学评估:血流动力学评估——2010年科隆共识会议推荐意见]
Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S78-86. doi: 10.1055/s-0030-1263315. Epub 2010 Sep 22.
3
[Non-invasive diagnosis of pulmonary hypertension: ESC/ERS Guidelines with commentary of the Cologne Consensus Conference 2010].
[肺动脉高压的无创诊断:欧洲心脏病学会/欧洲呼吸学会指南及2010年科隆共识会议评论]
Dtsch Med Wochenschr. 2010 Oct;135 Suppl 3:S67-77. doi: 10.1055/s-0030-1263314. Epub 2010 Sep 22.
4
[Diagnosis and treatment of pulmonary hypertension: European guidelines 2009].《肺动脉高压的诊断与治疗:2009年欧洲指南》
Pneumologie. 2010 Jul;64(7):401-14. doi: 10.1055/s-0029-1244112. Epub 2010 May 18.
5
Guidelines for the diagnosis and treatment of pulmonary hypertension.肺动脉高压诊断与治疗指南。
Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12.
6
[Pulmonary hypertension: pathophysiology, genetics and functional genomics].[肺动脉高压:病理生理学、遗传学与功能基因组学]
Internist (Berl). 2005 Jul;46(7):759-68. doi: 10.1007/s00108-005-1431-8.